国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Haemophilus influenzae Transcriptional regulator modE (modE) CSB-YP338153HTA
CSB-EP338153HTA
CSB-BP338153HTA
CSB-MP338153HTA
CSB-EP338153HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Lipopolysaccharide export system permease protein lptF (lptF), partial CSB-YP338154HTA1
CSB-EP338154HTA1
CSB-BP338154HTA1
CSB-MP338154HTA1
CSB-EP338154HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized transporter HI_1706 (HI_1706), partial CSB-YP338155HTA
CSB-EP338155HTA
CSB-BP338155HTA
CSB-MP338155HTA
CSB-EP338155HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Sensor protein qseC (qseC), partial CSB-YP338156HTA1
CSB-EP338156HTA1
CSB-BP338156HTA1
CSB-MP338156HTA1
CSB-EP338156HTA1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Glucose-specific phosphotransferase enzyme IIA component (crr) CSB-YP338157HTA
CSB-EP338157HTA
CSB-BP338157HTA
CSB-MP338157HTA
CSB-EP338157HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Undecaprenyl-phosphate alpha-N-acetylglucosaminyl 1-phosphate transferase (wecA), partial CSB-YP338158HTA
CSB-EP338158HTA
CSB-BP338158HTA
CSB-MP338158HTA
CSB-EP338158HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Penicillin-binding protein 1B (mrcB), partial CSB-YP338159HTA
CSB-EP338159HTA
CSB-BP338159HTA
CSB-MP338159HTA
CSB-EP338159HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae HTH-type transcriptional regulator metR (metR) CSB-YP338160HTA
CSB-EP338160HTA
CSB-BP338160HTA
CSB-MP338160HTA
CSB-EP338160HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heme/hemopexin-binding protein (hxuA), partial CSB-YP338161HSZ
CSB-EP338161HSZ
CSB-BP338161HSZ
CSB-MP338161HSZ
CSB-EP338161HSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Heme/hemopexin utilization protein C (hxuC), partial CSB-YP338162HSZ
CSB-EP338162HSZ
CSB-BP338162HSZ
CSB-MP338162HSZ
CSB-EP338162HSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium acetobutylicum Putative UDP-N-acetylglucosamine 2-epimerase (CA_C2874) CSB-YP338163DUB
CSB-EP338163DUB
CSB-BP338163DUB
CSB-MP338163DUB
CSB-EP338163DUB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant 3-hydroxybutyryl-CoA dehydrogenase (hbd) CSB-YP338164DUN
CSB-EP338164DUN
CSB-BP338164DUN
CSB-MP338164DUN
CSB-EP338164DUN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Poly-beta-hydroxybutyrate polymerase (phbC) CSB-YP338165TOC
CSB-EP338165TOC
CSB-BP338165TOC
CSB-MP338165TOC
CSB-EP338165TOC-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Allochromatium vinosum Poly-beta-hydroxybutyrate polymerase (phbC) CSB-YP338167AZP
CSB-EP338167AZP
CSB-BP338167AZP
CSB-MP338167AZP
CSB-EP338167AZP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Allochromatium vinosum Uncharacterized protein Alvin_0062 (Alvin_0062) CSB-YP338168AZP
CSB-EP338168AZP
CSB-BP338168AZP
CSB-MP338168AZP
CSB-EP338168AZP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Allochromatium vinosum Uncharacterized protein Alvin_0065 (Alvin_0065) CSB-YP338169AZP
CSB-EP338169AZP
CSB-BP338169AZP
CSB-MP338169AZP
CSB-EP338169AZP-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant S- (hydroxymethyl)glutathione dehydrogenase CSB-YP338170PBZ
CSB-EP338170PBZ
CSB-BP338170PBZ
CSB-MP338170PBZ
CSB-EP338170PBZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Vibrio cholerae serotype O1 Protein RecA (recA) CSB-YP338171VEX
CSB-EP338171VEX
CSB-BP338171VEX
CSB-MP338171VEX
CSB-EP338171VEX-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Immunoglobulin A1 protease autotransporter (iga), partial CSB-YP338172HSZ
CSB-EP338172HSZ
CSB-BP338172HSZ
CSB-MP338172HSZ
CSB-EP338172HSZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Pseudomonas putida Peptidyl-tRNA hydrolase CSB-YP338173FFZ
CSB-EP338173FFZ
CSB-BP338173FFZ
CSB-MP338173FFZ
CSB-EP338173FFZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>